Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

Clinical trial NCT05975307 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05975307
Sponsor: Sun Yat-sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Carcinoma Programmed Cell Death Protein 1 Inhibitor Radiotherapy

Start date: 2023-12-01
Primary completion: 2025-12-31
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.